RETRACTED: Long noncoding RNA OR3A4 promotes the migration and invasion of melanoma through the PI3K/AKT signaling pathway (Retracted article. See vol. 24, pg. 10917, 2020)

被引:8
|
作者
Wu, J. [1 ]
Zhou, M-Y [1 ]
Yu, X-P [1 ]
Wu, Y. [1 ]
Xie, P-L [2 ]
机构
[1] Peoples Hosp Gansu Prov, Dept Burns, Lanzhou, Gansu, Peoples R China
[2] Peoples Hosp Gansu Prov, Dept Plast Surg, Lanzhou, Gansu, Peoples R China
关键词
Long non-coding RNA; OR3A4; Melanoma; PI3K/AKT signaling pathway; PREDICTS POOR-PROGNOSIS; CELL-CYCLE ARREST; PROLIFERATION; METASTASIS; APOPTOSIS; CANCER;
D O I
10.26355/eurrev_201908_18739
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Recent studies have revealed the crucial role of long non-coding RNAs (lncRNAs) in tumor progression. This study aims to identify the biological function of lncRNA OR3A4 in the progression of melanoma. PATIENTS AND METHODS: OR3A4 expression in melanoma cells and tissue samples was detected by Real Time-quantitative Polymerase Chain Reaction (RT-qPCR), The regulatory effects of OR3A4 on melanoma cells were identified by performing transwell assay and wound healing assay in vitro. The underlying mechanism of OR3A4 in mediating the progression of melanoma was explored by RT-qPCR and Western blot. RESULTS: OR3A4 expression was remarkably upregulated in melanoma tissues compared with normal tissues. Moreover. migration and invasion of melanoma cells were inhibited after knockdown of OR3A4 in vitro, which were promoted after overexpression of OR3A4. Furthermore, the targeted proteins in phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway were downregulated after knockdown of OR3A4 in vitro, which were upregulated by overexpressed OR3A4. CONCLUSIONS: OR3A4 could promote the invasion and migration of melanoma cells by inducing the PI3K/AKT signaling pathway, which may offer a new therapeutic intervention for melanoma patients.
引用
收藏
页码:6991 / 6996
页数:6
相关论文
共 50 条
  • [1] RETRACTION: Long noncoding RNA OR3A4 promotes the migration and invasion of melanoma through the PI3K/AKT signaling pathway (Retraction of Vol 23, Pg 6991, 2019)
    Wu, J.
    Zhou, M. -Y.
    Yu, X. -P.
    Wu, Y.
    Xie, P. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 10917 - 10917
  • [2] RETRACTED: MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway (Retracted article. See vol. 24, pg. 7202, 2020)
    Fu, J. -H.
    Yang, S.
    Nan, C. -J.
    Zhou, C. -C.
    Lu, D. -Q.
    Li, S.
    Mu, H. -Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (02) : 351 - 357
  • [3] RETRACTED: LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway (Retracted article. See vol. 25, pg. 2460, 2021)
    Lei, Y.
    Wang, Y. -H.
    Wang, X. -F.
    Bai, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (19) : 6315 - 6323
  • [4] RETRACTED: Long non-coding RNA OR3A4 facilitates cell proliferation and migration in colorectal cancer through the Wnt/β-catenin signaling pathway (Retracted article. See vol. 25, pg. 3149, 2021)
    Sun, W.
    Chen, G. -R.
    Wang, J.
    Yu, X. -Y.
    Hao, X. -F.
    Hu, M. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (10) : 5360 - 5366
  • [5] RETRACTED: Shikonin inhibits proliferation, migration, invasion and promotes apoptosis in NCI-N87 cells via inhibition of PI3K/AKT signal pathway (Publication with Expression of Concern. See vol. 48, pg. 716, 2020) (Retracted article. See vol. 48, pg. 1252, 2020)
    Jia, Liushun
    Zhu, Zhen
    Li, Hongbo
    Li, Yaofeng
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 2662 - 2669
  • [6] RETRACTED: VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway(Retracted article. See vol. 75, pg. 255, 2017)
    Zhao, Jian
    Zhang, Zi-Ru
    Zhao, Na
    Ma, Bao-An
    Fan, Qing-Yu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 12411 - 12417
  • [7] RETRACTED: FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway (Retracted article. See vol. 25, pg. 2159, 2021)
    Li, Z. -Q.
    Qu, M.
    Wan, H. -X.
    Wang, H.
    Deng, Q.
    Zhang, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 9978 - 9987
  • [8] RETRACTED: Long noncoding RNA LUCAT1 promotes migration and invasion of prostate cancer cells by inhibiting KISS1 expression (Retracted article. See vol. 24, pg. 7213, 2020)
    Liu, C.
    Wang, L.
    Li, Y-W
    Cui, Y-S
    Wang, Y-Q
    Liu, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (08) : 3277 - 3283
  • [9] RETRACTED: Neferine hinders choriocarcinoma cell proliferation, migration and invasion through repression of long noncoding RNA-CHRF (Retracted article. See vol. 48, pg. 998, 2020)
    Wang, Gang
    Wang, Ping
    Yan, Xiaojun
    Liu, Jing
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 4089 - 4096
  • [10] RETRACTED: Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells (Retracted article. See vol. 63, 2023)
    Tian, Feng
    Ding, Ding
    Li, Dandan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (06) : 2355 - 2363